Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment
The medicine doubled survival time for patients in a Phase 3 clinical trial.
Latest news and analysis on pharma from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
The medicine doubled survival time for patients in a Phase 3 clinical trial.
The companies say the treatment slowed melanoma recurrence and spread in the trial.
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
It’s one of a growing number of partnerships between the pharmaceutical and, tech industries.
Experts say tariffs are creating uncertainty and shaking up biotech playbooks.
Companies are looking at combining several hormone-like molecules to boost results.
A recent study from JAMA highlights what some worry are gaps in regulation.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.